NCT07055958Active, not recruitingPhase 3
Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients
Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients: Randomized, Double Blind, Placebo Controlled Trial
Source: ClinicalTrials.gov · Last updated 9 Jul 2025
Brief summary (registry, in English)
The goal of this clinical trial is to learn that metformin has effect on motor aspects of daily living and oxidative stress in levodopa treated Parkinson disease patients. Researcher will compare drug metformin to a placebo. Participants will take metformin or placebo for 8 weeks.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 74 (estimated)
- First submitted
- 30 May 2025
- Start date
- 29 Dec 2024
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- Diseases
- Parkinson disease
- NCT number
- NCT07055958
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 74
- From 29 Dec 2024 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior stereotactic surgery for PD
Other illness
- Suffering from active malignancy
- Known hypersensitivity to metformin
Other
- Secondary causes of Parkinsonism
- Pregnancy or lactation
Who the study is looking for
- Diagnosed mild to moderate PD patients taking Levodopa
- Age 18 years and older
- Sex : Any
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| BSMMU Coordinator of this site? Confirm its status | Dhaka | Bangladesh | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.